Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Wu, ML; Huang, QR; Xie, Y; Wu, XY; Ma, HB; Zhang, YW; Xia, Y

Zhang, YW; Xia, Y (通讯作者),Sichuan Univ, Dept Rehabil Med, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.;Zhang, YW; Xia, Y (通讯作者),Sichuan Univ, Ctr Canc, Natl Clin Res Ctr Geriatr, West China Hosp, Chengdu 610041, Peoples R China.

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022; 15 (1):

Abstract

Immune checkpoint molecules are promising anticancer targets, among which therapeutic antibodies targeting the PD-1/PD-L1 pathway have been widely app......

Full Text Link